CYTOVENE INJ 500MG/VIAL DIN 00865516
Health Canada record
| Active ingredient(s) | GANCICLOVIR SODIUM 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AB06 GANCICLOVIR |
| Original market date | 31-Dec-1990 |
| Current status date | 30-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Syntex S.A. — licence , not currently licensed, last inspection rating I (2025-11-11).
No Canadian shortage report is currently matched to this DIN.
International API supply for GANCICLOVIR SODIUM
1 active FDA Drug Master Files.
Request a quote for CYTOVENE INJ 500MG/VIAL